Medlive Technology Co., Ltd.

SEHK:2192 株式レポート

時価総額:HK$6.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Medlive Technology 過去の業績

過去 基準チェック /46

Medlive Technologyは、平均年間41.2%の収益成長を遂げていますが、 Healthcare Services業界の収益は、年間 成長しています。収益は、平均年間15.2% 22.6%収益成長率で 成長しています。 Medlive Technologyの自己資本利益率は5.4%であり、純利益率は58.8%です。

主要情報

47.3%

収益成長率

39.8%

EPS成長率

Healthcare Services 業界の成長22.3%
収益成長率20.9%
株主資本利益率6.4%
ネット・マージン60.2%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Sep 27
Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

収支内訳

Medlive Technology の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SEHK:2192 収益、費用、利益 ( )CNY Millions
日付収益収益G+A経費研究開発費
30 Jun 244822901960
31 Mar 244472661870
31 Dec 234122421770
30 Sep 233842161670
30 Jun 233561891580
31 Mar 233351531550
31 Dec 223141171510
30 Sep 22300831430
30 Jun 22286481350
31 Mar 22285441310
31 Dec 21284411280
30 Sep 21270551090
30 Jun 2125570890
31 Mar 2123478710
31 Dec 2021485530
31 Dec 1912231370
31 Dec 188314310

質の高い収益: 2192 非現金収入 のレベルが高いです。

利益率の向上: 2192の現在の純利益率 (58.8%)は、昨年(37.4%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 2192の収益は過去 5 年間で年間41.2%増加しました。

成長の加速: 2192の過去 1 年間の収益成長率 ( 106.5% ) は、5 年間の平均 ( 年間41.2%を上回っています。

収益対業界: 2192の過去 1 年間の収益成長率 ( 106.5% ) はHealthcare Services業界11.1%を上回りました。


株主資本利益率

高いROE: 2192の 自己資本利益率 ( 5.4% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘